Innovative research sheds light on migraine mechanisms and potential therapies

FHS
July 5, 2024
2:19 am

New research describes for the first time how a spreading wave of disruption and the flow of fluid in the brain triggers headaches, detailing the connection between the neurological symptoms associated with aura and the migraine that follows.

Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD) – Biotech Investments

EQS-News: Somagenetix AG / Key word(s): Financing/Personnel Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous

October 9, 2024

India’s DCGI approves Orchid Pharma’s API Enmetazobactam

The United Nations and the World Health Organization have declared AMR to be a “silent pandemic”. Credit: nobeastsofierce / Shutterstock. Orchid Pharma has secured approval

June 6, 2024

Wood cookstove use linked to gastric cancer risk

Researchers conducted a population-based study with a case–control design in rural areas of Honduras in Central America to examine whether wood cookstove use by indigenous

October 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.